代谢仿生导向的中西医融升路径  

The Path of Chinese and Western Medicine Integration and Development Guided by Metabolic Bionics

作　　者：郑啸 郝海平[1] Xiao Zheng;Haiping Hao(School of Pharmaceutical Sciences,China Pharmaceutical University,Nanjing 210009)

机构地区：[1]中国药科大学药学院,南京210009

出　　处：《中国科学基金》2024年第3期440-445,共6页Bulletin of National Natural Science Foundation of China

基　　金：国家自然科学基金创新研究群体项目(82321005)的资助。

摘　　要：中医和西医各有优缺点,且具有互补性。中西医结合已成为我国医学体系的重要特色,但中西医理论与实践的深度融合与发展仍有待突破。本文针对复杂慢病的临床诊疗需求,梳理了推动中西医融升、构建新医学理论体系亟需解决的关键科学技术难题,阐释了代谢调控在促进中西医理论融合、满足临床治疗需求中的潜在作用,进而从“代谢仿生”角度提出了中西医融合促进慢病治疗策略创新与组合新药研发的可能路径,以期为全人类健康贡献中国医学智慧。Traditional Chinese Medicine and Western medicine each have their own advantages and disadvantages,and they complement each other.The integration of Chinese and Western medicine has become an important feature of China's medical system.However,deep integration and progression of Chinese and Western medicine theory and practice are still to be expected.In light of the needs for modern clinical diagnosis and treatment of chronic complex diseases,we outline the key scientific and technological challenges that need to be solved to promote the integration of Chinese and Western medicine toward a new medical theory system.We also discuss the value of metabolic regulation in promoting such an integration and progression.Lastly,we propose a“metabolic bionics”-directed path to promote the innovation of chronic disease treatment strategies and the development of combined new drugs,contributing Chinese medical wisdom to all humanity.

关 键 词：中西医融合 新医学 代谢仿生 新药研发 

分 类 号：R2-031[医药卫生—中西医结合]